Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors’ offices to quickly diagnose people infected with the virus that causes COVID-19.
Sanofi CEO Paul Hudson pitches 12 blockbusters in a bid to convince investors on boosting R&D spend
Four years ago, Paul Hudson welcomed investors and analysts to Sanofi’s Cambridge, MA office, introducing his strategy for the French pharma giant. Hudson, who joined